Patents Assigned to DIOSPHARMA CO., LTD.
  • Publication number: 20220339199
    Abstract: Provided is a method for preventing or treating a retinal degenerative disease, comprising administering to a subject in need thereof human neural crest-derived nasal inferior turbinate stem cells as an active ingredient, in which the stem cells are differentiated into rod photoreceptor cells among photoreceptor cells expressing rhodopsin and prevent or treat a retinal degenerative disease including age-related macular degeneration.
    Type: Application
    Filed: April 15, 2022
    Publication date: October 27, 2022
    Applicants: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DIOSPHARMA CO., LTD.
    Inventors: Sung Won Kim, In Beom KIM, Yong Soo PARK, Sang Jae SOUK